Tardive Dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements.
Ingrezza (Valbenazine) for Tardive Dyskinesia: Understanding Treatment
Tardive Dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements. These movements often affect the face, such as grimacing, blinking, or lip smacking, but can also appear in the limbs or torso. TD can significantly impact an individual's quality of life and social interactions. Fortunately, advancements in medicine have provided targeted treatment options, one of which is Ingrezza (valbenazine).
What is Ingrezza (Valbenazine)?
Ingrezza is a prescription medication approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of Tardive Dyskinesia in adults. Its active ingredient is valbenazine, which belongs to a class of drugs known as VMAT2 (vesicular monoamine transporter 2) inhibitors. Ingrezza is taken orally, typically once a day.
How Does Ingrezza Work?
The precise cause of Tardive Dyskinesia is complex, but it is believed to involve an imbalance in dopamine signaling in the brain, often linked to long-term use of certain dopamine receptor blocking medications, such as antipsychotics. Ingrezza works by selectively inhibiting VMAT2, a protein responsible for packaging neurotransmitters like dopamine into vesicles before their release. By reducing the excessive release of dopamine, Ingrezza helps to restore a more balanced neurotransmitter environment, thereby decreasing the involuntary movements associated with TD.
Who is Ingrezza For?
Ingrezza is intended for adults who have received a diagnosis of Tardive Dyskinesia. It is not a cure for TD, but rather a treatment designed to help manage and reduce the severity of the involuntary movements. The decision to prescribe Ingrezza, and its suitability for an individual, is made by a healthcare professional after a thorough evaluation of the patient's medical history and current condition.
Important Considerations Before Taking Ingrezza
Consultation with a Healthcare Professional
Before starting Ingrezza, it is crucial to have a comprehensive discussion with your doctor. They will assess your overall health, review your medical history, including any pre-existing conditions (especially heart problems or liver impairment), and evaluate all other medications you are currently taking to avoid potential drug interactions. Open communication with your healthcare provider is essential for safe and effective treatment.
Potential Side Effects
Like all medications, Ingrezza can cause side effects. Common side effects may include drowsiness (somnolence), fatigue, nausea, dry mouth, or changes in heart rhythm (QT prolongation). It is important to discuss any side effects you experience with your doctor, who can provide guidance on managing them or adjust your treatment plan if necessary. Serious side effects are rare but should be reported to your doctor immediately.
Dosage and Administration
The dosage of Ingrezza is determined by your healthcare provider and is tailored to your individual needs and response to treatment. It is important to follow your doctor's instructions precisely regarding how to take the medication, including the dose and schedule. Do not adjust your dose or stop taking Ingrezza without consulting your healthcare provider.
Managing Tardive Dyskinesia
Treatment for Tardive Dyskinesia often involves a multi-faceted approach. While medications like Ingrezza play a vital role in managing symptoms, ongoing communication with your healthcare team is paramount. Regular follow-ups ensure that the treatment remains effective and any concerns or changes in your condition are addressed promptly. Working closely with your doctor can lead to better management of TD and an improved quality of life.